The aim of this study was to elucidate the contributions of urea cycle enzymes, argininosuccinate synthase 1 (ASS1), and argininosuccinate lyase (ASL) towards ccRCC progression. The gene discussed is ASL; the disease is nonpapillary renal cell carcinoma.